NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has decreased by 2.3% and is now trading at $31.26. View which stocks have been most impacted by Coronavirus.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 6 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) released its earnings results on Wednesday, May, 6th. The company reported ($0.12) EPS for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.08. The business earned $4.19 billion during the quarter, compared to the consensus estimate of $3.44 billion. Nutrien had a net margin of 4.49% and a return on equity of 4.66%. The firm's revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.20 EPS. View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Wednesday, May 6th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 annualized dividend and a dividend yield of 5.76%. The ex-dividend date is Monday, June 29th. View Nutrien's dividend history.

Nutrien issued an update on its FY20 earnings guidance on Wednesday, May, 6th. The company provided EPS guidance of $1.50-2.10 for the period, compared to the Thomson Reuters consensus estimate of $2.00.

21 brokerages have issued 1 year price objectives for Nutrien's shares. Their forecasts range from $36.00 to $70.00. On average, they anticipate Nutrien's share price to reach $49.30 in the next year. This suggests a possible upside of 57.7% from the stock's current price. View analysts' price targets for Nutrien.

News headlines about NTR stock have been trending negative on Friday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nutrien earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Nutrien.

Nutrien saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 2,550,000 shares, a decrease of 10.8% from the June 15th total of 2,860,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the short-interest ratio is presently 1.6 days. Currently, 0.5% of the company's stock are short sold. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Eden Research (EDEN), Evogene (EVGN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA) and SenesTech (SNES). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.03%), PM CAPITAL Ltd (0.03%), Addenda Capital Inc. (0.02%), Cardinal Capital Management Inc. (0.00%) and Carroll Financial Associates Inc. (0.00%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Addenda Capital Inc., and Envestnet Asset Management Inc..

NTR stock was acquired by a variety of institutional investors in the last quarter, including PM CAPITAL Ltd, Cardinal Capital Management Inc., and Carroll Financial Associates Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $31.26.

Nutrien has a market capitalization of $17.81 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]